Product

CLN-418

Aliases

HBM7008

1 clinical trial

1 indication

Indication

Advanced Solid Tumor

Clinical trial

A Phase 1 Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CLN-418 in Subjects With Advanced Solid Tumors

Status: Recruiting, Estimated PCD: 2024-06-01